The level of mRNA was determined by real-time RT-PCR. A time-dependent induction was observed; B, Representative results of immunoblotting of PLK-1 expression in HeLa cells were shown. C, PLK-1 protein in HeLa cells increased after PLK-1 transfection, but decreased following siRNA transfection. The level of protein was determined by immunoblotting. A time-dependent modulation was observed. Data were the means of three independent experiments. * P < 0.05 compared to the control. PLK-1 knock-down by siRNA transfection modulated

HeLa cell survival We next evaluated the functional consequences of PLK-1 knock-down on the survival of HeLa cells by morphological buy BI 10773 examination. As illustrated in Fig 3, we observed enhanced apoptosis Selleck Inhibitor Library in HeLa cells after PLK-1 knock-down with or without cisplatin treatment, as indicated by typical nuclear condensation and cellular shrinkage as determined by Hoechst staining. We then quantitated the number of condensed nuclei per field for several fields. The numbers of condensed nuclei in groups A (control), B (PLK-1), C (PLK-1 siRNA), D (PLK-1 plus cisplatin) were 2.5

(0-7), 6.2 (0-13), 22.7 (5-65), 35.5 (9-77) (condensed nuclei/mm3), click here respectively; the results were significant (P < 0.05). Figure 3 PLK-1 knock-down by siRNA transfection modulated apoptosis in HeLa cells. A, Control; B, Cells transfected with PLK-1; C, Cells transfected with PLK-1 siRNA; D, Cells transfected with PLK-1 siRNA and treated with cisplatin (4 μg/ml) (original magnification, 200×); Enhanced apoptosis was demonstrated in B, C and D by typical nuclear condensation after siRNA transfection, as determined by Hoechst staining. Three independent experiments were performed. Representative fluorescent images are presented. To determine whether PLK-1 influences HeLa cell survival, we examined cell cycle characteristics and apoptosis after PLK-1 knockdown by flow cytometry. As shown in Fig. 4, we observed that PLK-1 siRNA significantly decreased G1/S arrest of HeLa cells from 64.5% to 32.5% (P < 0.05). Conversely, G2/M arrest

of HeLa cells increased significantly from 34.6% to 67.7% (P < 0.05). These findings suggested that PLK-1 knockdown contributed to cell http://www.selleck.co.jp/products/Temsirolimus.html cycle progression. In contrast, PLK-1 transfection significantly increased G1/S arrest and decreased G2/M arrest in HeLa cells. Figure 4 PLK-1 knock-down modulated cell cycle characteristics and apoptosis in cisplatin-treated HeLa cells. A synergistic effect with cisplatin treatment (4 μg/ml) was demonstrated. A, PLK-1 siRNA significantly decreased G1/S arrest but enhanced G2/M arrest of HeLa cells; B, PLK-1 siRNA significantly enhanced the apoptosis of HeLa cells, demonstrating a synergistic effect with cisplatin treatment. Representative results of flow cytometric analysis are presented. Data were the means of three independent experiments. * P < 0.